EDITORIAL
Published on 19 Jun 2024
Editorial: Commercialization and industrialization of pharmacology of infectious diseases: 2022
doi 10.3389/fphar.2024.1438072
- 501 views
- Frontiers in Pharmacology
- Pharmacology of Infectious Diseases
- Research Topics
- Commercialization and Industrialization of Pharmacology of Infectious Diseases: 2022
Commercialization and Industrialization of Pharmacology of Infectious Diseases: 2022
4,735
Total downloads
18k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 26 Jul 2023
Individualized antibiotic dosage regimens for patients with augmented renal clearance
doi 10.3389/fphar.2023.1137975
- 6,200 views
- 10 citations
ORIGINAL RESEARCH
Published on 28 Apr 2023
Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
doi 10.3389/fphar.2023.1132367
- 3,342 views
- 3 citations
ORIGINAL RESEARCH
Published on 13 Jan 2023
Development and validation of two bioanalysis methods for the determination of etimicin in human serum and urine by liquid chromatography-tandem mass spectrometry: Applications to a human pharmacokinetic and breakpoint study
doi 10.3389/fphar.2023.1076046
- 1,435 views
- 3 citations
ORIGINAL RESEARCH
Published on 14 Nov 2022
Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections
doi 10.3389/fphar.2022.1035841
- 2,391 views
- 15 citations
ORIGINAL RESEARCH
Published on 18 Jul 2022
Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae
doi 10.3389/fphar.2022.856792
- 3,070 views
- 4 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Infectious Diseases
Impact
- 18kTopic views
- 13kArticle views
- 4,735Article downloads